trial,pubID,pseudogroup,weeks,group,IgD-/IgM-/IgA-/IgG+/KO-/Antigen++ B cells
G002,G002-852,G002,24,1,2276.0
G002,G002-678,G002,24,1,2630.0
G002,G002-509,G002,24,1,1564.0
G002,G002-813,G002,24,1,1430.0
G002,G002-502,G002,24,1,1554.0
G002,G002-758,G002,24,1,1573.0
G002,G002-616,G002,24,1,440.0
G002,G002-546,G002,24,1,787.0
G002,G002-302,G002,24,1,1005.0
G002,G002-969,G002,24,1,484.0
G002,G002-619,G002,24,1,571.0
G002,G002-905,G002,24,1,297.0
G002,G002-834,G002,24,1,62.0
